Macleods Pharma recalls 50mg Losartan Potassium Tablets due to AZIDO impurity levels exceeding safety limits. Affected lots include BLI2002A through BLI2104B. Contact for return instructions.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Macleods Pharma is recalling 50mg Losartan Potassium Tablets that may contain unsafe levels of AZIDO impurities. This could pose a health risk if taken by patients. The recall covers specific bottle counts and lot numbers.
The recall is for AZIDO impurities found in the medication that exceed acceptable safety levels. These impurities could potentially cause health issues if the medication is taken as directed.
Patients prescribed Losartan Potassium Tablets by a doctor are affected. Those with the specific lot numbers and bottle counts listed are most at risk.
Check for 50mg Losartan Potassium Tablets in 30-count, 90-count, or 1000-count bottles with the NDC numbers listed. The lot numbers include BLI2002A, BLI2004A, and BLI2104B.
Identify the NDC numbers and lot numbers on your medication bottle to confirm if it is affected.
The recall indicates potential unsafe levels of AZIDO impurities, so it is not safe to take without confirming it is not recalled.
The recall does not specify a remedy, so contact the manufacturer for instructions on how to handle affected products.
Affected lot numbers include BLI2002A, BLI2004A, and BLI2104B.
We’ve drafted a message you can send Macleods Pharma to request your refund or repair — edit it as you like.
Subject: Recall D-0833-2022 — Macleods Pharma Macleods Pharma Hello, I own a Macleods Pharma that is covered by recall D-0833-2022 from Macleods Pharma. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
